Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.21.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2021
Dec. 31, 2020
Current Assets:    
Cash and cash equivalents $ 50,796 $ 47,667 [1]
Accounts receivable, net (net of allowance for doubtful accounts of $363 and $260, respectively) 67,043 43,491 [1]
Inventories 58,251 37,925 [1]
Prepaid inventory 531 891 [1]
Derivative instruments 28,498 17,149 [1]
Assets held-for-sale 30,199 58,295 [1]
Other current assets 8,932 8,628 [1]
Total current assets 244,250 214,046 [1]
Property and equipment, net 221,327 229,486 [1]
Other Assets:    
Right of use operating lease assets, net 13,509 11,046 [1]
Notes receivable 12,775 14,337 [1]
Intangible assets 2,678 2,678 [1]
Other assets 4,665 5,225 [1]
Total other assets 33,627 33,286 [1]
Total Assets 499,204 476,818 [1]
Current Liabilities:    
Accounts payable – trade 30,029 13,047 [1]
Accrued liabilities 15,977 11,101 [1]
Current portion – operating leases 3,171 2,180 [1]
Current portion – long-term debt 23,660 25,533 [1]
Derivative instruments 20,174  
Liabilities held-for-sale 10,478 19,542 [1]
Other current liabilities 7,255 15,524 [1]
Total current liabilities 110,744 86,927 [1]
Long-term debt, net of current portion 56,848 71,807 [1]
Operating leases, net of current portion 10,188 8,715 [1]
Other liabilities 13,405 13,134 [1]
Total Liabilities 191,185 180,583 [1]
Commitments and Contingencies (Note 7)
Alto Ingredients, Inc. Stockholders’ Equity:    
Preferred stock, $0.001 par value; 10,000 shares authorized; Series A: 1,684 shares authorized; no shares issued and outstanding as of June 30, 2021 and December 31, 2020; Series B: 1,581 shares authorized; 927 shares issued and outstanding as of June 30, 2021 and December 31, 2020; liquidation preference of $20,290 as of June 30, 2021 1 1 [1]
Common stock, $0.001 par value; 300,000 shares authorized; 72,811 and 72,487 shares issued and outstanding as of June 30, 2021 and December 31, 2020, respectively 73 72 [1]
Additional paid-in capital 1,035,980 1,036,638 [1]
Accumulated other comprehensive loss (3,878) (3,878) [1]
Accumulated deficit (724,157) (736,598) [1]
Total Stockholders’ Equity 308,019 296,235 [1]
Total Liabilities and Stockholders’ Equity 499,204 476,818 [1]
Non-Voting Common Stock    
Alto Ingredients, Inc. Stockholders’ Equity:    
Common stock, $0.001 par value; 300,000 shares authorized; 72,811 and 72,487 shares issued and outstanding as of June 30, 2021 and December 31, 2020, respectively
[1] Amounts derived from the audited consolidated financial statements for the year ended December 31, 2020.